September 27, 2025
New York, NY – A significant political declaration aimed at bolstering global efforts against non-communicable diseases (NCDs) like cardiovascular disease, diabetes, and cancer, as well as promoting mental health, has hit a roadblock at the United Nations General Assembly, with the United States reportedly voicing objections. Robert F. Kennedy Jr., a prominent environmental lawyer and health advocate, has publicly highlighted these concerns, suggesting they stem from a desire to protect the interests of pharmaceutical companies.
The declaration represents the culmination of years of work and five months of formal negotiations involving governments, health experts, and civil society organizations worldwide. It is designed to provide a comprehensive roadmap for prevention, control, and the promotion of mental well-being, addressing what is widely recognized as a growing global health crisis.
While the specifics of the US objections have not been fully detailed, sources close to the negotiations suggest that disagreements may center on the scope of proposed measures, particularly those that could impact the pharmaceutical industry's access to markets or influence over public health policies.
"It is deeply concerning that at a time when millions are suffering from preventable diseases, the United States is reportedly creating obstacles to a vital global agreement," stated an observer familiar with the UN's health agenda. "These diseases are a massive burden on individuals, families, and economies, and a unified international approach is crucial."
Robert F. Kennedy Jr. has been a vocal critic of the pharmaceutical industry's influence on public health decisions. In statements addressing the stalled declaration, he has alluded to potential conflicts of interest being a driving force behind the US position. "We are seeing once again how powerful corporate interests can overshadow the health and well-being of people around the globe," Kennedy Jr. reportedly commented. "This declaration offers a chance to prioritize prevention and the broader determinants of health, but it seems some are more concerned with protecting profits than preventing suffering."
NCDs are the leading cause of death and disability worldwide, accounting for an estimated 74% of all deaths globally. The economic cost is also staggering, impacting productivity and healthcare systems immensely. The UN declaration was intended to galvanize political will and secure commitments from member states to implement evidence-based strategies to tackle this complex challenge.
The delay raises questions about the commitment of key players to addressing this critical global health issue. As negotiations continue, the international community will be watching closely to see if a consensus can be reached, ensuring that the momentum built over years of dedicated work is not lost. The implications of a weakened or stalled declaration could have far-reaching consequences for global health equity and the fight against NCDs for years to come.
Read also:
UN Declaration on Noncommunicable Diseases Fails to Win Approval After US Foils Consensus.